Crescent Capital BDC (NASDAQ:CCAP) Issues Earnings Results, Misses Expectations By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01), Zacks reports. Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%.

Crescent Capital BDC Stock Performance

Shares of CCAP stock remained flat at $20.00 during trading hours on Wednesday. 145,729 shares of the stock traded hands, compared to its average volume of 86,210. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. Crescent Capital BDC has a twelve month low of $16.18 and a twelve month high of $20.19. The firm has a 50 day moving average price of $19.47 and a 200-day moving average price of $18.85. The company has a market cap of $741.20 million, a PE ratio of 7.84 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were given a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 8.40%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 65.88%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CCAP. Keefe, Bruyette & Woods upped their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. Wells Fargo & Company upped their price objective on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Check Out Our Latest Analysis on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.